JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202469200 on May 3, 2002

J. Biol. Chem., Vol. 277, Issue 29, 25893-25903, July 19, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/29/25893    most recent
M202469200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kane, R.
Right arrow Articles by Martin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kane, R.
Right arrow Articles by Martin, F.

Transcription Factor NFIC Undergoes N-Glycosylation during Early Mammary Gland Involution*

Rosemary KaneDagger §, Janice MurtaghDagger §, Darren FinlayDagger §, Andreas Marti||, Rolf Jaggi, David Blatchford**, Colin Wilde**, and Finian MartinDagger §Dagger Dagger

From the Dagger  Conway Institute of Biomolecular and Biomedical Research and § Department of Pharmacology, University College Dublin, Belfield, Dublin 4, Ireland,  Department of Clinical Research University of Bern, Murtenstrasse 35, Bern, CH-3010 Switzerland, and ** Hannah Research Institute, Ayr, Scotland KA6 5HL, United Kingdom

Expression of a 74-kDa nuclear factor I (NFI) protein is triggered in early involution in the mouse mammary gland, and its expression correlates with enhanced occupation of a twin (NFI) binding element in the clusterin promoter, a gene whose transcription is induced at this time (Furlong, E. E., Keon, N. K., Thornton, F. D., Rein, T., and Martin, F. (1996) J. Biol. Chem. 271, 29688-29697). We now identify this 74-kDa NFI as an NFIC isoform based on its interaction in Western analysis with two NFIC-specific antibodies. A transition from the expression of a 49-kDa NFIC in lactation to the expression of the 74-kDa NFIC in early involution is demonstrated. We show that the 74-kDa NFIC binds specifically to concanavalin A (ConA) and that this binding can be reversed by the specific ConA ligands, methyl alpha -D-mannopyranoside and methyl alpha -D-glucopyranoside. In addition, its apparent molecular size was reduced to ~63 kDa by treatment with the peptide N-glycosidase. The 49-kDa lactation-associated NFIC did not bind ConA nor was it affected by peptide N-glycosidase. Tunicamycin, a specific inhibitor of N-glycosylation, blocked formation of the 74-kDa NFI in involuting mouse mammary gland in vivo when delivered from implanted Elvax depot pellets. Finally, the production of the ConA binding activity could be reiterated in "mammospheres" formed from primary mouse mammary epithelial cells associated with a laminin-rich extracellular matrix. Synthesis of the 74-kDa NFIC was also inhibited in this setting by tunicamycin. Thus, involution triggers the production of an NFIC isoform that is post-translationally modified by N-glycosylation. We further show, by using quantitative competitive reverse transcriptase-PCR, that there is increased expression of the major mouse mammary NFIC mRNA transcript, mNFIC2, in early involution, suggesting that the involution-associated change in NFIC expression also has a transcriptional contribution.


* This work was supported by the Health Research Board, Ireland and Enterprise Ireland, the Irish Science and Technology Agency.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF358455-AF358460.

|| Present address: Novartis Pharma AG, Oncology Research, WKL-125.2.42, 4002 Basel, Switzerland.

Dagger Dagger To whom correspondence should be addressed: Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland. Tel.: 353-1-716-2808; Fax: 353-1-269-2016; E-mail: finian.martin@ucd.ie.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
S. Fauquenoy, W. Morelle, A. Hovasse, A. Bednarczyk, C. Slomianny, C. Schaeffer, A. Van Dorsselaer, and S. Tomavo
Proteomics and Glycomics Analyses of N-Glycosylated Structures Involved in Toxoplasma gondii-Host Cell Interactions
Mol. Cell. Proteomics, May 1, 2008; 7(5): 891 - 910.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Ouellet, F. Vigneault, M. Lessard, S. Leclerc, R. Drouin, and S. L. Guerin
Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells
Nucleic Acids Res., December 2, 2006; 34(22): 6472 - 6487.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Triantis, V. Moulin, M. W. G. Looman, F. C. Hartgers, R. A. J. Janssen, and G. J. Adema
Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT
J. Leukoc. Biol., May 1, 2006; 79(5): 1083 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. M. Johansson, M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson
Nuclear Factor 1-C2 Is Regulated by Prolactin and Shows a Distinct Expression Pattern in the Mouse Mammary Epithelial Cells during Development
Mol. Endocrinol., April 1, 2005; 19(4): 992 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. K. Wickenheisser, V. L. Nelson-DeGrave, P. G. Quinn, and J. M. McAllister
Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1
Mol. Endocrinol., March 1, 2004; 18(3): 588 - 605.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Cotman, D. Jezek, K. F. Tacer, R. Frangez, and D. Rozman
A Functional Cytochrome P450 Lanosterol 14{alpha}-Demethylase CYP51 Enzyme in the Acrosome: Transport through the Golgi and Synthesis of Meiosis-Activating Sterols
Endocrinology, March 1, 2004; 145(3): 1419 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
P. V. Minorsky

Plant Physiology, September 1, 2003; 133(1): 14 - 15.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Luciakova, P. Barath, D. Poliakova, A. Persson, and B. D. Nelson
Repression of the Human Adenine Nucleotide Translocase-2 Gene in Growth-arrested Human Diploid Cells: THE ROLE OF NUCLEAR FACTOR-1
J. Biol. Chem., August 15, 2003; 278(33): 30624 - 30633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.